Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Trimetazidine was identified without a priori hypothesis using a gene-expression signature for the effects of a combination of drugs used to treat bipolar disorder and screening a library of off-patent drugs in cultured human neuronal-like cells
Months or even years after a viral infection, many individuals find themselves battling a relentless array of symptomscrushing fatigue, persistent brain fog, and severe autonomic dysfunction
Description Overview BPC157 in lyophilized powder form packaged in a sealed glass research vial
Premium formulation, fair pricing
Patients should monitor for severe abdominal pain, persistent vomiting, dehydration, or unexplained hypoglycemia and report these to their healthcare provider
Component Pharmacology
US$ 23.47
US$ 25.51
US$ 25.85
US$ 27.26
